Skip to content

Tick-Borne Encephalitis Vaccine - TGA Unlicensed Products


HL Pharma has exclusive distribution rights for numerous products and also specialises in sourcing and supply of products that are unlicensed in Australia.

These products may not have TGA registration or maybe an Australian product with supply issues. They are usually supplied under The Special Access Scheme (SAS) or Authorised Prescriber Scheme (APS). Other pathways to supply include Clinical Trial Supply.

For more product information on Tick-Borne Encephalitis Vaccine or other brands including FSME-IMMUN® see below, or for further information on sourcing this product or any others, please don't hesitate to contact us.



Tick-Borne Encephalitis Vaccine

What is Tick-Borne Encephalitis?

Tick-borne encephalitis (TBE) is a viral infection that attacks the central nervous system and can result in serious meningitis, brain inflammation, and in some instances death.  It is caused by three different virus sub-types: European, Far Eastern, Siberian, and endemic in regions of at least 27 European countries, and parts of Central and Eastern Asia including Northern Japan and Northern China.  Risk areas have expanded over the past 3 years and TBE now represents a significant public health concern for many regions in Europe and beyond. 

TBE Symptoms

Tick-borne encephalitis incubation is 6-14 days initially causing an increase in temperature, headaches, fever, and flu-like symptoms.  Around one-third of these symptomatic cases will go on to develop a second more dangerous phase of TBE which can lead to encephalitis, meningitis, paralysis, coma, or in some instances death.  People over 60 have a higher risk of neurological abnormalities and death.  For those with severe disease who recover, long-term effects of the illness such as cognitive deficits, limb weakness, or difficulty in walking or coordination may occur. 

How is Tick-Borne Encephalitis Treated?

There is no anti-viral treatment or medications available for TBE infections. 

Tick-Borne Encephalitis Vaccine

Although there is no treatment for TBE, there is a vaccine that can be used as a preventative measure against the disease. However, the vaccine is not yet licensed in Australia.  For more information on sourcing the Tick-borne Encephalitis vaccine and brands including FSME-IMMUN® which are available for use in Australia, contact us today. F

or more product information on Tick-Borne Ence
HL Pharma is a specialist supplier of medicines from overseas. Please contact us for assistance or further information on obtaining vaccines or medicines from overseas.